Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Leerink Partnrs Analysts Raise Earnings Estimates for BrightSpring Health Services, Inc. (NASDAQ:BTSG)

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) - Equities researchers at Leerink Partnrs upped their Q2 2024 earnings per share estimates for shares of BrightSpring Health Services in a research report issued on Tuesday, May 7th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $0.15 per share for the quarter, up from their prior estimate of $0.14. Leerink Partnrs currently has a "Outperform" rating on the stock. The consensus estimate for BrightSpring Health Services' current full-year earnings is $0.67 per share. Leerink Partnrs also issued estimates for BrightSpring Health Services' Q3 2024 earnings at $0.17 EPS, Q4 2024 earnings at $0.19 EPS, FY2024 earnings at $0.66 EPS, Q1 2025 earnings at $0.18 EPS, Q2 2025 earnings at $0.21 EPS, Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.26 EPS, FY2025 earnings at $0.88 EPS, FY2026 earnings at $1.11 EPS and FY2027 earnings at $1.35 EPS.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its earnings results on Thursday, May 2nd. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.06. The firm had revenue of $2.58 billion for the quarter, compared to analyst estimates of $2.31 billion. BrightSpring Health Services's revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the company posted ($0.10) EPS.


BTSG has been the subject of several other research reports. Wells Fargo & Company raised their price target on shares of BrightSpring Health Services from $15.00 to $16.00 and gave the company an "overweight" rating in a research report on Monday. Guggenheim started coverage on BrightSpring Health Services in a research report on Tuesday, February 20th. They issued a "buy" rating and a $15.00 price target on the stock. The Goldman Sachs Group lowered their price objective on BrightSpring Health Services from $26.00 to $23.00 and set a "buy" rating for the company in a research report on Monday, March 4th. Bank of America began coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued a "buy" rating and a $14.00 target price on the stock. Finally, HSBC initiated coverage on shares of BrightSpring Health Services in a report on Wednesday, March 6th. They set a "buy" rating and a $13.00 price target for the company. Eleven research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $15.85.

View Our Latest Report on BrightSpring Health Services

BrightSpring Health Services Stock Up 1.2 %

Shares of BTSG traded up $0.14 during mid-day trading on Thursday, hitting $11.51. 893,456 shares of the company's stock were exchanged, compared to its average volume of 2,049,180. The company has a debt-to-equity ratio of 5.73, a quick ratio of 0.84 and a current ratio of 1.17. The company has a 50-day moving average of $10.06. BrightSpring Health Services has a fifty-two week low of $7.85 and a fifty-two week high of $12.14.

Insider Activity at BrightSpring Health Services

In other news, insider James F. Mattingly, Jr. bought 12,280 shares of the business's stock in a transaction dated Thursday, March 14th. The shares were acquired at an average price of $8.18 per share, for a total transaction of $100,450.40. Following the completion of the transaction, the insider now owns 128,700 shares of the company's stock, valued at $1,052,766. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other BrightSpring Health Services news, insider James F. Mattingly, Jr. purchased 12,280 shares of the firm's stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $8.18 per share, for a total transaction of $100,450.40. Following the purchase, the insider now directly owns 128,700 shares in the company, valued at $1,052,766. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jennifer A. Phipps bought 12,300 shares of BrightSpring Health Services stock in a transaction dated Thursday, March 14th. The stock was acquired at an average cost of $8.14 per share, with a total value of $100,122.00. Following the completion of the acquisition, the chief accounting officer now directly owns 165,618 shares of the company's stock, valued at approximately $1,348,130.52. The disclosure for this purchase can be found here.

Institutional Investors Weigh In On BrightSpring Health Services

Several large investors have recently modified their holdings of BTSG. Capstone Investment Advisors LLC acquired a new stake in BrightSpring Health Services in the first quarter valued at about $9,722,000. BNP Paribas Financial Markets purchased a new position in shares of BrightSpring Health Services during the 1st quarter worth approximately $280,000. Finally, Seven Grand Managers LLC acquired a new stake in shares of BrightSpring Health Services in the 1st quarter valued at approximately $1,630,000.

BrightSpring Health Services Company Profile

(Get Free Report)

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Read More

Earnings History and Estimates for BrightSpring Health Services (NASDAQ:BTSG)

Should you invest $1,000 in BrightSpring Health Services right now?

Before you consider BrightSpring Health Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.

While BrightSpring Health Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: